Publikationen suchen
- Publikation
- Autoren
- Einrichtungen
- Abstract
- Externe Dokumente
- Links
A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52)
(
Zeitschriftenartikel
)
